214 related articles for article (PubMed ID: 1921634)
1. Development of monoclonal antibodies with specificity to oral squamous cell carcinoma.
Fantozzi RD
Laryngoscope; 1991 Oct; 101(10):1076-80. PubMed ID: 1921634
[TBL] [Abstract][Full Text] [Related]
2. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody (G10) to a common antigen of human squamous cell carcinoma: binding of the antibody to the H type 2 blood group determinant.
Kimmel KA; Carey TE; Judd WJ; McClatchey KD
J Natl Cancer Inst; 1986 Jan; 76(1):9-19. PubMed ID: 2416979
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
Brenner BG; Jothy S; Shuster J; Fuks A
Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
[TBL] [Abstract][Full Text] [Related]
5. Antigens associated with human squamous cell lung carcinoma defined by murine monoclonal antibodies.
Fernsten PD; Pekny KW; Reisfeld RA; Walker LE
Cancer Res; 1986 Jun; 46(6):2970-7. PubMed ID: 3009005
[TBL] [Abstract][Full Text] [Related]
6. [Monoclonal antibodies against squamous epithelial carcinomas of the upper aerodigestive tract].
Görögh T; Lippert BM; Paulsen JI; Folz BJ; Gottschlich S; Sabzeghabari M; Werner JA
Laryngorhinootologie; 1996 Nov; 75(11):677-81. PubMed ID: 9063836
[TBL] [Abstract][Full Text] [Related]
7. Reactivity of monoclonal antibody 17.13. with human squamous cell carcinoma and its application to tumor diagnosis.
Ranken R; White CF; Gottfried TG; Yonkovich SJ; Blazek BE; Moss MS; Fee WE; Liu YS
Cancer Res; 1987 Nov; 47(21):5684-90. PubMed ID: 3311357
[TBL] [Abstract][Full Text] [Related]
8. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung.
Hanai N; Shitara K; Yoshida H
Cancer Res; 1986 Sep; 46(9):4438-43. PubMed ID: 3731100
[TBL] [Abstract][Full Text] [Related]
9. [Possibilities for using monoclonal antibodies in diagnosis and therapy of head and neck cancers. I. Introduction and current state].
Wustrow TP
HNO; 1991 Mar; 39(3):82-90. PubMed ID: 2050556
[TBL] [Abstract][Full Text] [Related]
10. [A monoclonal antibody reactive with human squamous cell carcinoma of the esophagus].
Tomita Y
Nihon Geka Gakkai Zasshi; 1994 Jul; 95(7):425-34. PubMed ID: 7520969
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody against human ovarian tumor-associated antigens.
Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P
J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies (Mabs) in head and neck cancer.
Poliquin JF; Filion LG
J Otolaryngol; 1986 Oct; 15(5):289-92. PubMed ID: 3534285
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
[TBL] [Abstract][Full Text] [Related]
14. A novel marker for basal (stem) cells of mammalian stratified squamous epithelia and squamous cell carcinomas.
Samuel J; Noujaim AA; Willans DJ; Brzezinska GS; Haines DM; Longenecker BM
Cancer Res; 1989 May; 49(9):2465-70. PubMed ID: 2468409
[TBL] [Abstract][Full Text] [Related]
15. Oral premalignant lesions induce immune reactivity to both premalignant oral lesions and head and neck squamous cell carcinoma.
Young MR; Neville BW; Chi AC; Lathers DM; Boyd Gillespie M; Day TA
Cancer Immunol Immunother; 2007 Jul; 56(7):1077-86. PubMed ID: 17096152
[TBL] [Abstract][Full Text] [Related]
16. [Preparation and specificity of monoclonal antibodies against human lung carcinoma].
Ruan ST
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1985 Apr; 8(2):65-70, 125. PubMed ID: 4006625
[No Abstract] [Full Text] [Related]
17. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J
Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
Sauter ER; Nesbit M; Watson JC; Klein-Szanto A; Litwin S; Herlyn M
Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical identification of squamous carcinoma of the head and neck with monoclonal antibody SQM1.
Böheim K; Schwarzfurtner H; Böheim C; Frei E; Bernal SD
Acta Otolaryngol; 1986; 102(3-4):333-40. PubMed ID: 3535370
[TBL] [Abstract][Full Text] [Related]
20. Oncofetal antigen expression in head and neck carcinoma.
Gussack GS
Laryngoscope; 1992 Feb; 102(2):168-76. PubMed ID: 1738289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
